CVS CVS Health Corporation Common Stock
$93,59
Cena · Sie 21, 2026
Dane fundamentalne na dzień Sie 5, 2026
Zakres 52 tyg.
$70–$111
58% of range
Ocena Analityków
BUY
33 analysts
Cena Docelowa
$116
+24% upside
P/E (TTM)
67.3
ROE
2.4%
Marża Zysku Netto
0.44%
O CVS Health Corporation Common Stock Przegląd firmy z Wikipedii
CVS Health – amerykańska firma branży farmaceutycznej i zdrowotnej z siedzibą w Woonsocket, w hrabstwie Providence, w stanie Rhode Island, zarządzająca ponad 7800 aptekami CVS Pharmacy i Longs Drugs. Firma jest właścicielem CVS/caremark, jednej z największych amerykańskich firm obsługujących świadczenia recept farmaceutycznych oraz CVS/minuteclinick, sieci szybkich przychodni przy aptekach CVS/pharmacy. W roku 2014 CVS Health zajęła 35. miejsce na liście największych światowych firm Fortune Global 500 oraz 12. miejsce w rankingu największych firm amerykańskich Fortune 500.
Czytaj więcej
CVS Health (wcześniej CVS Caremark Corporation) – amerykańska firma branży farmaceutycznej i zdrowotnej z siedzibą w Woonsocket, w hrabstwie Providence, w stanie Rhode Island, zarządzająca ponad 7800 aptekami CVS Pharmacy i Longs Drugs. Firma jest właścicielem CVS/caremark, jednej z największych amerykańskich firm obsługujących świadczenia recept farmaceutycznych (pharmacy benefit management) oraz CVS/minuteclinick, sieci szybkich przychodni (walk-in clinic) przy aptekach CVS/pharmacy. W roku 2014 CVS Health zajęła 35. miejsce na liście największych światowych firm Fortune Global 500 oraz 12. miejsce w rankingu największych firm amerykańskich Fortune 500.
== Przypisy ==
Źródło: Wikipedia, CC BY-SA 4.0 · Zobacz w Wikipedii ↗
CVS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$93.58
Kapitalizacja Rynkowa
$118.95B
P/E (TTM)
67.3
EPS (TTM)
$1.39
Przychody (TTM)
$402.07B
Stopa dywidendy
2.9%
ROE
2.4%
D/E Dług/Kapitał
0.0
Zakres 52 tyg.
$70 – $111
CVS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$402.07B
2017-12-31
→
2025-12-31
EPS
$1.39
2017-12-31
→
2025-12-31
Wolny przepływ pieniężny
$7.81B
2017-12-31
→
2025-12-31
Marże
0.44%
2017-12-31
→
2017-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
CVS
Mediana porównawcza
P/E (TTM)
67.3
42.6
P/S (TTM)
0.3
0.3
P/B
1.6
0.9
EV / EBITDA
11.7
—
Price / FCF (Cena / FCF)
15.2
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
CVS
Mediana porównawcza
Operating Margin (Marża Operacyjna)
1.2%
—
Net Profit Margin (Marża Zysku Netto)
0.44%
-7.0%
ROA
0.70%
-10.6%
ROE
2.4%
-20.8%
ROIC
5.0%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
CVS
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.0
8.0
Current Ratio (Wskaźnik bieżący)
0.8
1.1
Quick Ratio (Wskaźnik Szybkości)
0.6
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
CVS
Mediana porównawcza
Revenue YoY (Przychody R/R)
7.8%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
7.6%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
8.4%
—
EPS YoY
-62.0%
—
Net Income YoY (Zysk Netto R/R)
-61.7%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
CVS
Mediana porównawcza
Payout Ratio (Wskaźnik Wypłaty Dywidendy)
192.1%
—
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy
2.9%
Wskaźnik Wypłaty Dywidendy
192.1%
CAGR dywidendy 5-letni
—
| Data ex-dywidendy | Kwota |
|---|---|
| 23 lipca 2026 | $0,6650 |
| 23 kwietnia 2026 | $0,6650 |
| 22 stycznia 2026 | $0,6650 |
| 23 października 2025 | $0,6650 |
| 22 lipca 2025 | $0,6650 |
| 22 kwietnia 2025 | $0,6650 |
| 23 stycznia 2025 | $0,6650 |
| 21 października 2024 | $0,6650 |
| 22 lipca 2024 | $0,6650 |
| 19 kwietnia 2024 | $0,6650 |
| 19 stycznia 2024 | $0,6650 |
| 19 października 2023 | $0,6050 |
| 20 lipca 2023 | $0,6050 |
| 20 kwietnia 2023 | $0,6050 |
| 19 stycznia 2023 | $0,6050 |
| 20 października 2022 | $0,5500 |
| 21 lipca 2022 | $0,5500 |
| 21 kwietnia 2022 | $0,5500 |
| 20 stycznia 2022 | $0,5500 |
| 21 października 2021 | $0,5000 |
CVS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
33 analityków
- Mocne kupno 8 24,2%
- Kup 20 60,6%
- Trzymaj 5 15,2%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
25 analityków · 2026-08-17
Mediana
$116.00
← Poniżej wszystkich celów
$93.58
Niski
$103.00
Wysoki
$148.00
Średni cel
$116.00
+24,0%
Średnia cel
$116.08
+24,0%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.37%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $2.58 | $1.87 | 0.71% |
| 31 marca 2026 | $2.57 | $2.22 | 0.35% |
| 31 grudnia 2025 | $1.09 | $1.00 | 0.09% |
| 30 września 2025 | $1.60 | $1.38 | 0.22% |
| 30 czerwca 2025 | $1.81 | $1.47 | 0.34% |
| 31 marca 2025 | $2.25 | $1.72 | 0.53% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Cost of Revenue | $221.17B | $206.29B | $217.10B | $196.89B | $175.80B | $163.98B | $158.72B | · | $153.45B | $146.53B | $126.76B | |
| Gross Profit | · | · | · | · | · | · | · | · | $28.55B | $28.86B | $26.53B | |
| Operating Expenses | $397.41B | $364.29B | $344.03B | $314.51B | $278.80B | $254.79B | $244.79B | · | $18.81B | $18.45B | $17.05B | |
| Operating Income | $4.66B | $8.52B | $13.74B | $7.95B | $13.31B | $13.91B | $11.99B | · | $9.54B | $10.39B | $9.47B | |
| Interest Expense | · | · | $2.66B | $2.29B | $2.50B | $2.91B | $3.04B | · | $1.06B | $1.08B | $859M | |
| Interest Income | · | · | · | · | · | · | · | · | $21M | $20M | $21M | |
| Other Non-op | $112M | $99M | $88M | $169M | $182M | $206M | $124M | · | $-208M | $-28M | · | |
| Pretax Income | $2.14B | $6.15B | $11.17B | $5.84B | $10.54B | $9.77B | $9.00B | · | $8.27B | $8.64B | $8.62B | |
| Income Tax | $408M | $1.56B | $2.81B | $1.51B | $2.55B | $2.57B | $2.37B | · | $1.64B | $3.32B | $3.39B | |
| Net Income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| EPS (Basic) | $1.40 | $3.67 | $6.49 | $3.29 | $6.07 | $5.48 | $5.10 | · | $6.47 | $4.93 | $4.66 | |
| EPS (Diluted) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | · | $6.44 | $4.90 | $4.63 | |
| Shares (Basic) | 1,267,000,000 | 1,259,000,000 | 1,285,000,000 | 1,312,000,000 | 1,319,000,000 | 1,309,000,000 | 1,301,000,000 | · | 1,020,000,000 | 1,073,000,000 | 1,118,000,000 | |
| Shares (Diluted) | 1,271,000,000 | 1,262,000,000 | 1,290,000,000 | 1,323,000,000 | 1,329,000,000 | 1,314,000,000 | 1,305,000,000 | · | 1,024,000,000 | 1,079,000,000 | 1,126,000,000 | |
| EBITDA | $9.27B | $13.11B | $18.11B | $11.99B | $17.70B | $18.35B | $16.36B | · | $12.00B | $10.34B | $9.45B |
Bilans 31
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.45B | $8.59B | $8.20B | $12.95B | $9.41B | $7.85B | $5.68B | · | $1.70B | $3.37B | $2.46B | |
| Short-term Investments | $2.15B | $2.41B | $3.26B | $2.78B | $3.12B | $3.00B | $2.37B | · | $111M | $87M | $88M | |
| Receivables | $39.78B | $36.47B | $35.23B | $27.28B | $24.43B | $21.74B | $19.62B | · | $13.18B | $12.16B | $11.89B | |
| Inventory | $19.25B | $18.11B | $18.02B | $19.09B | $17.76B | $18.50B | $17.52B | · | $15.30B | $14.76B | $14.00B | |
| Other Current Assets | $5.09B | $3.08B | $3.15B | $2.64B | $5.29B | $5.28B | $5.11B | $4.53B | $945M | $660M | $722M | |
| Current Assets | $74.71B | $68.64B | $67.86B | $65.63B | $60.01B | $56.37B | $50.30B | $45.20B | $31.23B | $31.04B | $29.16B | |
| PP&E (Net) | · | · | · | $12.87B | $12.90B | $12.61B | $12.04B | $11.36B | $10.29B | $10.18B | $9.86B | |
| PP&E (Gross) | · | · | · | $34.60B | $33.55B | $31.31B | $28.93B | · | $24.29B | $22.80B | $21.04B | |
| Accum. Depreciation | · | · | · | $21.48B | $20.65B | $18.70B | $16.89B | · | $14.00B | $12.63B | $11.18B | |
| Goodwill | $85.48B | $91.27B | $91.27B | $78.15B | $79.12B | $79.55B | $79.75B | · | $38.45B | $38.25B | $38.11B | |
| Intangibles | $25.51B | $27.32B | $29.23B | $24.80B | $29.03B | $31.14B | $33.12B | $36.31B | $13.63B | $13.51B | $13.88B | |
| Other Non-current Assets | $7.11B | $4.79B | $4.66B | $4.62B | $4.71B | $4.62B | $4.60B | $4.53B | $1.42B | $1.49B | $1.44B | |
| Total Assets | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | $216.67B | $95.13B | $94.46B | $92.44B | |
| Accounts Payable | · | · | · | · | · | · | · | · | $8.86B | $7.95B | $7.49B | |
| Accrued Liabilities | $22.39B | $20.81B | $23.52B | $18.75B | $17.67B | $14.24B | $12.13B | $10.66B | $6.58B | $6.94B | $6.83B | |
| Short-term Debt | $0 | $2.12B | $200M | $0 | · | $0 | $0 | · | $1.28B | $1.87B | $0 | |
| Current Liabilities | $88.69B | $84.61B | $79.19B | $69.42B | $67.81B | $62.02B | $53.30B | $45.76B | $30.65B | $26.25B | $23.17B | |
| Capital Leases | $13.64B | $14.90B | $16.03B | $16.80B | $18.18B | $18.76B | $18.93B | $18.83B | $306M | · | · | |
| Deferred Tax | $3.83B | $3.81B | $4.31B | $4.02B | $6.27B | $6.79B | $7.29B | $7.74B | $3.00B | $4.21B | $4.22B | |
| Other Non-current Liabilities | $6.77B | $5.43B | $6.21B | $6.73B | $1.90B | $2.35B | $2.16B | $2.26B | $1.28B | $1.55B | $1.54B | |
| Total Liabilities | $178.16B | $177.49B | $173.09B | $156.51B | $157.62B | $161.01B | $158.28B | $157.95B | $57.44B | · | · | |
| Long-term Debt | · | · | · | · | · | · | $68.48B | $72.61B | $27.00B | $25.70B | $27.50B | |
| Total Debt | $0 | $2.12B | $200M | · | · | · | $3.78B | · | $27.00B | $27.53B | $27.46B | |
| Common Stock | · | $18M | $18M | $18M | $17M | $17M | $17M | · | $17M | $17M | $17M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $32.08B | $31.62B | $30.95B | |
| Retained Earnings | $61.20B | $62.84B | $61.60B | $56.40B | $54.91B | $49.64B | $45.11B | $41.09B | $43.56B | $38.98B | $35.51B | |
| Treasury Stock | $36.79B | $36.82B | $33.84B | $31.86B | $28.17B | $28.18B | $28.23B | · | $37.80B | $33.45B | $28.89B | |
| AOCI | $406M | $-120M | $-297M | $-1.26B | $965M | $1.41B | $1.02B | · | $-165M | $-305M | $-358M | |
| Stockholders' Equity | $75.21B | $75.56B | $76.46B | $71.47B | $75.08B | $69.39B | $63.86B | $58.40B | $37.69B | $36.83B | $37.20B | |
| Liabilities + Equity | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | · | $95.13B | $94.46B | $92.44B | |
| Shares Outstanding | 1,271,000,000 | 1,260,000,000 | 1,288,000,000 | 1,300,000,000 | 1,322,000,000 | 1,310,000,000 | 1,302,000,000 | · | 1,712,000,000 | 1,061,000,000 | 1,101,000,000 |
Przepływy pieniężne 19
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.61B | $4.60B | $4.37B | $4.22B | $4.49B | $4.44B | $4.37B | · | $2.48B | $2.48B | $2.09B | |
| Stock-based Comp | $535M | $540M | $588M | $447M | $484M | $400M | $453M | · | $234M | $222M | $230M | |
| Deferred Tax | $102M | $-572M | $-676M | $-2.03B | $-402M | $-564M | $-649M | · | $-1.42B | $3M | $-234M | |
| Amort. of Intangibles | $2.00B | $2.00B | $1.90B | $1.80B | $2.20B | $2.30B | $2.40B | · | $817M | $795M | $611M | |
| Restructuring | · | · | · | · | · | · | · | · | $215M | · | · | |
| Other Non-cash | $3.63B | $-72M | $804M | $9.41B | $5.79B | $4.41B | $2.04B | · | $93M | · | · | |
| Operating Cash Flow | $10.64B | $9.11B | $13.43B | $16.18B | $18.27B | $15.87B | $12.85B | · | $8.01B | $10.14B | $8.54B | |
| CapEx | $2.83B | $2.78B | $3.03B | $2.73B | $2.52B | $2.44B | $2.46B | · | $1.92B | $2.22B | $2.37B | |
| Investing Cash Flow | $-5.87B | $-7.61B | $-20.89B | $-5.05B | $-5.26B | $-5.53B | $-3.34B | · | $-2.88B | $-2.47B | $-13.42B | |
| Debt Issued | $3.97B | $7.91B | $10.90B | $0 | $987M | $9.96B | $3.74B | · | $0 | $3.46B | $14.80B | |
| Net Debt Issued | $340M | $3.14B | $7.73B | $-4.21B | $-9.27B | $-5.67B | $-4.60B | · | · | $-2.49B | $11.90B | |
| Stock Repurchased | $0 | $3.02B | $2.01B | $3.50B | $0 | $0 | $0 | · | $4.36B | $4.46B | $5.00B | |
| Net Stock Activity | $0 | $-3.02B | $-2.01B | $-3.50B | · | · | $0 | · | $-4.36B | $-4.46B | $-5.00B | |
| Dividends Paid | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B | |
| Financing Cash Flow | $-4.94B | $-1.14B | $2.68B | $-10.52B | $-11.36B | $-7.70B | $-7.65B | · | $-6.75B | $-6.76B | $4.88B | |
| Net Change in Cash | $-172M | $359M | $-4.78B | $614M | $1.65B | $2.63B | $1.85B | · | $-1.62B | $912M | $-22M | |
| Taxes Paid | $2.17B | $1.70B | $3.52B | $4.12B | $3.19B | $2.93B | $2.72B | · | $2.91B | $3.06B | $3.27B | |
| Free Cash Flow | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B | $13.43B | $10.39B | · | $6.09B | $7.84B | $6.04B | |
| Levered FCF | · | · | $8.40B | $11.76B | $13.85B | $11.29B | $8.15B | · | $5.24B | $7.18B | $5.52B |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 15.4% | 16.3% | 17.3% | |
| Operating Margin | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% | 5.2% | 4.7% | · | 5.1% | 5.8% | 6.2% | |
| Net Margin | 0.44% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% | 2.6% | · | 3.6% | 3.0% | 3.4% | |
| Pretax Margin | 0.53% | 1.7% | 3.1% | 1.8% | 3.6% | 3.6% | 3.5% | · | 4.5% | 4.9% | 5.6% | |
| EBITDA Margin | 2.3% | 3.5% | 5.1% | 3.7% | 6.1% | 6.8% | 6.4% | · | 6.5% | 5.8% | 6.2% | |
| ROA | 0.70% | 1.8% | 3.5% | 1.8% | 3.4% | 3.2% | 3.0% | · | 7.0% | 5.7% | 6.2% | |
| ROE | 2.4% | 6.1% | 11.3% | 5.7% | 10.9% | 10.8% | 10.8% | · | 17.8% | 14.4% | 13.9% | |
| ROIC | 5.0% | 8.2% | 13.4% | 8.1% | 13.3% | 14.8% | 13.1% | · | 11.8% | 9.9% | 8.9% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.2 | 1.3 | |
| Quick Ratio | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | · | · | · | 0.1 | · | 0.7 | 0.7 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | 0.6 | 0.7 | 0.7 | |
| Interest Coverage | · | · | 5.2 | 3.4 | 5.3 | 4.8 | 3.9 | · | 9.0 | 9.6 | 11.0 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.5 | 1.5 | 1.4 | 1.3 | 1.2 | 1.2 | · | 1.9 | 1.9 | 1.8 | |
| Inventory Turnover | 11.8 | 11.4 | 11.7 | 10.7 | 9.7 | 9.1 | 9.3 | · | 10.4 | 10.3 | 9.8 | |
| Receivables Turnover | 10.5 | 10.4 | 11.4 | 12.5 | 12.7 | 13.0 | 13.8 | · | 14.6 | 14.8 | 14.2 |
Stopy Wzrostu 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.8% | 4.2% | 10.9% | 10.4% | 8.7% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.6% | 8.5% | 10.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -62.0% | -43.4% | 98.5% | -45.9% | 10.3% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -24.7% | -15.3% | 5.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -23.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -61.7% | -44.7% | 93.5% | -46.1% | 11.5% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -25.7% | -16.8% | 5.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -24.4% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.3% | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Net Income TTM | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| Market Cap | $100.87B | $56.56B | $101.70B | $121.15B | $136.38B | $89.47B | $96.73B | · | $73.52B | $83.72B | $107.64B | |
| Enterprise Value | $90.27B | $47.69B | $90.45B | · | · | · | $92.45B | · | $98.71B | $107.80B | $132.56B | |
| P/E | 57.1 | 12.3 | 12.2 | 28.6 | 17.1 | 12.5 | 14.6 | · | 11.3 | 16.1 | 21.1 | |
| P/S | 0.3 | 0.2 | 0.3 | 0.4 | 0.5 | 0.3 | 0.4 | · | 0.4 | 0.5 | 0.7 | |
| P/B | 1.3 | 0.7 | 1.3 | 1.7 | 1.8 | 1.3 | 1.5 | · | 2.0 | 2.3 | 2.9 | |
| P / Cash Flow | 9.5 | 6.2 | 7.6 | 7.5 | 7.5 | 5.6 | 7.5 | · | 9.2 | 8.3 | 12.8 | |
| P / FCF | 12.9 | 8.9 | 9.8 | 9.0 | 8.7 | 6.7 | 9.3 | · | 12.1 | 10.7 | 17.8 | |
| EV / EBITDA | 9.7 | 3.6 | 5.0 | · | · | · | 5.7 | · | 8.2 | 10.4 | 14.0 | |
| EV / FCF | 11.6 | 7.5 | 8.7 | · | · | · | 8.9 | · | 16.2 | 13.7 | 21.9 | |
| EV / Revenue | 0.2 | 0.1 | 0.3 | · | · | · | 0.4 | · | 0.5 | 0.6 | 0.9 | |
| Dividend Yield | 3.4% | 6.0% | 3.1% | 2.4% | 1.9% | 2.9% | 2.7% | · | 2.8% | 2.2% | 1.5% | |
| Earnings Yield | 1.8% | 8.2% | 8.2% | 3.5% | 5.8% | 8.0% | 6.8% | · | 8.9% | 6.2% | 4.7% | |
| Payout Ratio | 192.1% | 73.1% | 37.5% | 70.1% | 33.2% | 36.5% | 39.2% | · | 30.9% | 34.6% | 30.1% | |
| Annual Payout | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | $94.59B | $97.71B | $95.43B | $91.23B | $88.44B | $93.81B | $89.76B | $88.92B | $85.28B | $83.85B | $81.16B | |
| Cost of Revenue | $58.86B | $55.44B | $59.06B | $57.05B | $54.01B | $51.06B | $55.27B | $52.95B | $50.00B | $48.07B | $57.42B | $54.69B | $53.54B | $51.45B | $51.73B | $50.37B | |
| Operating Expenses | $101.39B | $95.75B | $103.58B | $106.08B | $96.53B | $91.21B | $95.34B | $94.60B | $88.19B | $86.17B | $90.44B | $86.07B | $85.69B | $81.83B | $80.19B | $85.08B | |
| Operating Income | $4.70B | $4.68B | $2.11B | $-3.21B | $2.38B | $3.37B | $2.37B | $832M | $3.04B | $2.27B | $3.37B | $3.69B | $3.23B | $3.45B | $3.66B | $-3.92B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $716M | · | $693M | $686M | $589M | · | $566M | |
| Other Non-op | $31M | $32M | $29M | $26M | $29M | $28M | $25M | $25M | $24M | $25M | $22M | $22M | $22M | $22M | $43M | $41M | |
| Pretax Income | $3.98B | $3.94B | $1.35B | $-3.48B | $1.65B | $2.62B | $2.13B | $105M | $2.34B | $1.58B | $2.71B | $3.02B | $2.57B | $2.88B | $3.15B | $-4.44B | |
| Income Tax | $982M | $981M | $-1.57B | $508M | $634M | $835M | $503M | $34M | $569M | $456M | $658M | $754M | $656M | $737M | $818M | $-1.04B | |
| Net Income | $2.98B | $2.94B | $2.94B | $-3.98B | $1.02B | $1.78B | $1.64B | $87M | $1.77B | $1.11B | $2.05B | $2.26B | $1.90B | $2.14B | $2.33B | $-3.41B | |
| EPS (Basic) | $2.33 | $2.31 | $2.31 | $-3.13 | $0.81 | $1.41 | $1.31 | $0.07 | $1.41 | $0.88 | $1.59 | $1.76 | $1.48 | $1.66 | $1.78 | $-2.59 | |
| EPS (Diluted) | $2.31 | $2.30 | $2.31 | $-3.13 | $0.80 | $1.41 | $1.30 | $0.07 | $1.41 | $0.88 | $1.59 | $1.75 | $1.48 | $1.65 | $1.79 | $-2.59 | |
| Shares (Basic) | 1,279,000,000 | 1,273,000,000 | -2,529,000,000 | 1,269,000,000 | 1,266,000,000 | 1,261,000,000 | -2,516,000,000 | 1,259,000,000 | 1,256,000,000 | 1,260,000,000 | -2,568,000,000 | 1,287,000,000 | 1,283,000,000 | 1,283,000,000 | -2,628,000,000 | 1,315,000,000 | |
| Shares (Diluted) | 1,287,000,000 | 1,279,000,000 | -2,532,000,000 | 1,269,000,000 | 1,270,000,000 | 1,264,000,000 | -2,523,000,000 | 1,259,000,000 | 1,259,000,000 | 1,267,000,000 | -2,578,000,000 | 1,290,000,000 | 1,287,000,000 | 1,291,000,000 | -2,641,000,000 | 1,315,000,000 | |
| EBITDA | $5.83B | $5.79B | · | $-2.07B | $3.55B | $4.53B | · | $832M | $3.04B | $3.41B | · | $3.69B | $3.23B | $4.45B | · | $-3.93B |
Bilans 26
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.33B | $9.54B | $8.45B | $9.10B | $11.79B | $10.08B | $8.59B | $6.88B | $12.51B | $9.80B | $8.20B | $13.04B | $13.81B | $14.62B | $12.95B | $17.20B | |
| Short-term Investments | $2.63B | $2.26B | $2.15B | $2.13B | $2.39B | $2.58B | $2.41B | $2.81B | $3.75B | $3.29B | · | $3.15B | $3.08B | $3.10B | · | $2.79B | |
| Receivables | $40.31B | $40.99B | $39.78B | $43.86B | $40.65B | $39.62B | $36.47B | $36.18B | $32.38B | $32.22B | · | $32.93B | $29.55B | $28.33B | · | $26.32B | |
| Inventory | $17.62B | $17.77B | $19.25B | $18.96B | $17.45B | $17.39B | $18.11B | $17.65B | $16.07B | $16.35B | · | $17.95B | $17.29B | $18.26B | · | $18.06B | |
| Other Current Assets | $3.46B | $4.25B | $5.09B | $3.06B | $3.38B | $3.53B | $3.08B | $3.83B | $5.24B | $5.82B | · | $3.07B | $3.41B | $3.77B | · | $2.48B | |
| Current Assets | $75.35B | $74.82B | $74.71B | $77.11B | $75.65B | $73.19B | $68.64B | $67.34B | $69.95B | $67.47B | · | $70.14B | $67.76B | $68.71B | · | $68.34B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $13.02B | $13.00B | $12.87B | · | $12.63B | |
| Goodwill | $85.48B | $85.48B | $85.48B | $85.48B | $91.20B | $91.20B | $91.27B | $91.27B | $91.27B | $91.27B | $91.27B | $91.26B | $91.26B | $84.06B | $78.15B | $78.09B | |
| Intangibles | $24.64B | $25.07B | $25.51B | $25.98B | $26.22B | $26.57B | $27.32B | $27.82B | $28.31B | $28.77B | · | $29.62B | $30.12B | $26.37B | · | $25.16B | |
| Other Non-current Assets | $7.43B | $7.42B | $5.12B | $5.16B | $5.21B | $5.23B | $4.79B | $4.76B | $4.80B | $4.80B | · | $4.83B | $4.85B | $4.82B | · | $4.85B | |
| Total Assets | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Accrued Liabilities | $22.48B | $22.26B | $22.39B | $23.41B | $23.10B | $22.37B | $20.81B | $20.17B | $21.16B | $22.35B | · | $22.57B | $22.83B | $21.52B | · | $19.42B | |
| Short-term Debt | · | · | $0 | $1.25B | $3.04B | $1.26B | $2.12B | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Current Liabilities | $87.04B | $86.41B | $88.69B | $92.69B | $94.16B | $88.96B | $84.61B | $84.63B | $81.39B | $83.32B | · | $81.55B | $79.21B | $75.05B | · | $72.41B | |
| Capital Leases | $12.98B | $13.33B | $13.64B | $14.01B | $14.33B | $14.59B | $14.90B | $15.26B | $15.54B | $15.74B | · | $16.44B | $16.61B | $16.57B | · | $17.17B | |
| Deferred Tax | $3.77B | $3.77B | $3.83B | $3.55B | $3.60B | $3.66B | $3.81B | $3.63B | $4.05B | $4.18B | · | $4.25B | $4.59B | $4.09B | · | $3.51B | |
| Other Non-current Liabilities | $6.11B | $6.71B | $4.78B | $4.76B | $4.78B | $5.42B | $5.43B | $5.48B | $5.53B | $6.21B | · | $6.24B | $6.32B | $6.67B | · | $6.77B | |
| Total Liabilities | $173.87B | $175.34B | $178.16B | $182.22B | $180.79B | $178.47B | $177.49B | $177.32B | $177.37B | $175.59B | · | $176.80B | $177.07B | $167.75B | · | $160.20B | |
| Total Debt | · | · | · | $1.25B | $3.04B | $1.26B | · | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Common Stock | · | · | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | $18M | $18M | |
| Retained Earnings | $65.40B | $63.28B | $61.20B | $59.11B | $63.94B | $63.77B | $62.84B | $62.04B | $62.80B | $61.87B | · | $60.34B | $58.87B | $57.75B | · | $54.57B | |
| Treasury Stock | $36.85B | $36.71B | $36.79B | $36.78B | $36.85B | $36.73B | $36.82B | $36.81B | $36.92B | $36.77B | · | $33.83B | $33.93B | $33.80B | · | $30.33B | |
| AOCI | $188M | $201M | $406M | $416M | $272M | $59M | $-120M | $209M | $-319M | $-341M | · | $-1.00B | $-858M | $-875M | · | $-1.61B | |
| Stockholders' Equity | $79.70B | $77.46B | $75.21B | $72.93B | $77.38B | $76.93B | $75.56B | $74.94B | $74.93B | $73.97B | · | $74.34B | $72.73B | $71.38B | · | $70.68B | |
| Liabilities + Equity | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Shares Outstanding | 1,278,000,000 | 1,273,000,000 | 1,271,000,000 | 1,270,000,000 | 1,267,000,000 | 1,262,000,000 | 1,260,000,000 | 1,258,000,000 | 1,256,000,000 | 1,252,000,000 | · | 1,287,000,000 | 1,282,000,000 | 1,279,000,000 | · | 1,315,000,000 |
Przepływy pieniężne 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.13B | $1.11B | $1.15B | $1.13B | $1.17B | $1.15B | $1.15B | $1.16B | $1.15B | $1.14B | $1.13B | $1.13B | $1.10B | $1.00B | $1.04B | $1.04B | |
| Stock-based Comp | $176M | $266M | $135M | $138M | $136M | $126M | $137M | $133M | $133M | $137M | $127M | $154M | $204M | $103M | $106M | $105M | |
| Amort. of Intangibles | $431M | $442M | $507M | $500M | $494M | $499M | $478M | $507M | $507M | $508M | $504M | $509M | $485M | $402M | $420M | $458M | |
| Other Non-cash | · | $-75M | · | · | · | $1.50B | · | · | · | $2.52B | · | · | · | $4.20B | · | · | |
| Operating Cash Flow | $6.34B | $4.25B | $3.39B | $796M | $1.90B | $4.56B | $1.86B | $-745M | $3.09B | $4.90B | $-2.64B | $2.72B | $5.91B | $7.44B | $-1.95B | $9.12B | |
| CapEx | $691M | $849M | $784M | $698M | $607M | $743M | $768M | $670M | $638M | $705M | $911M | $545M | $591M | $984M | $688M | $580M | |
| Investing Cash Flow | $-1.88B | $-874M | $-2.00B | $-2.09B | $-1.02B | $-762M | $-547M | $-3.35B | $-1.62B | $-2.09B | $-1.24B | $-771M | $-10.36B | $-8.51B | $-119M | $-805M | |
| Debt Issued | · | · | $0 | $3.97B | · | · | $2.95B | $0 | $4.96B | $0 | $0 | $0 | $4.95B | $5.95B | $0 | $0 | |
| Net Debt Issued | · | $-1.52B | · | · | · | $-743M | · | · | · | $-18M | · | · | · | $5.59B | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $0 | $0 | $0 | $-1M | $-3M | $3.03B | $-1M | $-3M | $-2M | $2.02B | $1.50B | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-3.03B | · | · | · | $-2.02B | · | · | |
| Dividends Paid | $878M | $847M | $845M | $846M | $866M | $840M | $838M | $837M | $858M | $840M | $779M | $779M | $795M | $779M | $719M | $726M | |
| Financing Cash Flow | $-2.69B | $-2.32B | $-2.03B | $-1.38B | $806M | $-2.33B | $431M | $-1.59B | $1.25B | $-1.23B | $-972M | $-2.70B | $3.63B | $2.73B | $-2.19B | $-3.22B | |
| Net Change in Cash | $1.77B | $1.06B | $-640M | $-2.67B | $1.68B | $1.46B | $1.74B | $-5.68B | $2.71B | $1.58B | $-4.85B | $-752M | $-828M | $1.65B | $-4.26B | $5.10B | |
| Taxes Paid | $374M | $-337M | $998M | $305M | $725M | $138M | $274M | $700M | $666M | $63M | $908M | $837M | $1.70B | $75M | $1.05B | $1.18B | |
| Free Cash Flow | · | $3.40B | · | · | · | $3.81B | · | · | · | $4.20B | · | · | · | $6.45B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $3.69B | · | · | · | $6.02B | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.4% | 4.7% | · | -3.1% | 2.4% | 3.6% | · | 0.87% | 3.3% | 2.6% | · | 4.1% | 3.6% | 4.0% | · | -4.8% | |
| Net Margin | 2.8% | 2.9% | · | -3.9% | 1.0% | 1.9% | · | 0.09% | 1.9% | 1.3% | · | 2.5% | 2.1% | 2.5% | · | -4.2% | |
| Pretax Margin | 3.8% | 3.9% | · | -3.4% | 1.7% | 2.8% | · | 0.11% | 2.6% | 1.8% | · | 3.4% | 2.9% | 3.4% | · | -5.5% | |
| EBITDA Margin | 5.5% | 5.8% | · | -2.0% | 3.6% | 4.8% | · | 0.87% | 3.3% | 3.9% | · | 4.1% | 3.6% | 5.2% | · | -4.8% | |
| ROA | 1.2% | 1.2% | · | -1.6% | 0.40% | 0.70% | · | 0.03% | 0.70% | 0.46% | · | 0.94% | 0.79% | 0.90% | · | -1.5% | |
| ROE | 3.8% | 3.8% | · | -5.4% | 1.3% | 2.4% | · | 0.12% | 2.4% | 1.5% | · | 3.1% | 2.6% | 2.9% | · | -4.7% | |
| ROIC | 4.4% | 4.5% | · | -5.0% | 1.8% | 2.9% | · | 0.74% | 3.1% | 2.1% | · | 3.7% | 3.3% | 3.6% | · | -4.2% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | 0.0 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | 5.3 | 4.7 | 5.9 | · | -6.9 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | |
| Inventory Turnover | 3.4 | 3.2 | · | 3.1 | 3.2 | 3.0 | · | 3.0 | 3.0 | 2.8 | · | 3.0 | 3.1 | 2.8 | · | 2.8 | |
| Receivables Turnover | 2.6 | 2.5 | · | 2.6 | 2.7 | 2.6 | · | 2.8 | 2.9 | 2.9 | · | 3.0 | 3.1 | 3.1 | · | 3.1 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $408.31B | $396.80B | · | $391.80B | $380.17B | $369.69B | · | $364.86B | $358.36B | $352.40B | · | $345.12B | $335.99B | $323.90B | · | $312.42B | |
| Net Income TTM | $2.97B | $1.77B | · | $-1.09B | $4.66B | $4.75B | · | $5.23B | $7.04B | $7.41B | · | $2.89B | $3.66B | $4.11B | · | $3.58B | |
| Market Cap | $132.21B | $91.43B | · | $95.75B | $87.40B | $85.50B | · | $79.10B | $74.18B | $99.86B | · | $89.86B | $88.62B | $95.04B | · | $125.41B | |
| Enterprise Value | · | · | · | $85.76B | $76.26B | $74.11B | · | $70.22B | $57.92B | $89.49B | · | · | $72.74B | · | · | · | |
| P/E | 45.4 | 52.0 | · | -88.7 | 18.7 | 18.0 | · | 15.3 | 10.7 | 13.8 | · | 30.5 | 24.4 | 23.8 | · | 35.7 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| P/B | 1.7 | 1.2 | · | 1.3 | 1.1 | 1.1 | · | 1.1 | 1.0 | 1.4 | · | 1.2 | 1.2 | 1.3 | · | 1.8 | |
| P / Cash Flow | · | 21.5 | · | · | · | 18.8 | · | · | · | 20.4 | · | · | · | 12.8 | · | · | |
| P / FCF | · | 26.9 | · | · | · | 22.4 | · | · | · | 23.8 | · | · | · | 14.7 | · | · | |
| EV / EBITDA | · | · | · | -41.4 | 21.5 | 16.4 | · | 84.4 | 19.0 | 26.3 | · | · | 22.5 | · | · | · | |
| EV / FCF | · | · | · | · | · | 19.4 | · | · | · | 21.3 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | · | 0.2 | · | · | · | |
| Earnings Yield | 2.2% | 1.9% | · | -1.1% | 5.3% | 5.6% | · | 6.5% | 9.3% | 7.2% | · | 3.3% | 4.1% | 4.2% | · | 2.8% | |
| Payout Ratio | · | 28.8% | · | · | · | 47.2% | · | · | · | 75.5% | · | · | · | 36.5% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B |
| Marża Operacyjna % | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% |
| Zysk netto | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B |
| Rozwodniony EPS | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.0 | 0.0 | 0.0 | — | — |
| Wskaźnik bieżący | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 |
| Wskaźnik Szybkości | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- As Americans go direct with GLP-1 prescriptions, Walmart, Costco, Amazon will be big weight-loss winners
- What A Patient Holder Is Really Paying For CVS Health Stock
- Aktualizacja Rynku: CVS, ETN, KMB, KO, PSX
- Jim Cramer o CVS: „Twierdzę, że jest tańszy”
- Dlaczego akcje CVS wzrosły w środę
- Jim Cramer wysuwa poważne twierdzenie dotyczące CVS Corporation (CVS)
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 2 292 emitenci · $77.0B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 312 (+119 vs poprzedni kw.) | 93 (-95 vs poprzedni kw.) | 797 (+96 vs poprzedni kw.) | 722 (-51 vs poprzedni kw.) | +62.2M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $8 618 974 924 | 83 315 369 | 11,20% | Akcje |
| Capital World Investors | $7 753 834 783 | 74 951 955 | 10,07% | Akcje |
| STATE STREET CORP | $6 236 318 558 | 60 283 408 | 8,10% | Akcje |
| Dodge & Cox | $5 173 820 539 | 50 012 765 | 6,72% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $3 266 370 439 | 31 574 388 | 4,24% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 755 624 444 | 26 637 259 | 3,58% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $2 646 473 316 | 25 714 722 | 3,44% | Akcje |
| Capital Research Global Investors | $2 516 851 376 | 24 329 151 | 3,27% | Akcje |
| NORGES BANK | $1 866 126 481 | 18 038 922 | 2,42% | Akcje |
| FMR LLC | $1 684 924 609 | 16 287 333 | 2,19% | Akcje |
| Capital International Investors | $1 591 868 430 | 15 387 600 | 2,07% | Akcje |
| Davis Selected Advisers | $1 227 594 458 | 11 865 916 | 1,59% | Akcje |
| Clearbridge Investments, LLC | $878 119 687 | 8 488 349 | 1,14% | Akcje |
| GQG Partners LLC | $822 989 370 | 7 955 411 | 1,07% | Akcje |
| AMERIPRISE FINANCIAL INC | $761 355 564 | 7 357 966 | 0,99% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $741 242 940 | 7 165 229 | 0,96% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $643 180 166 | 6 217 304 | 0,84% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $524 415 257 | 5 069 263 | 0,68% | Akcje |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $499 125 457 | 4 824 799 | 0,65% | Akcje |
| CITADEL ADVISORS LLC | $493 765 609 | 4 772 988 | 0,64% | Akcje |
| VIKING GLOBAL INVESTORS LP | $378 974 695 | 3 663 361 | 0,49% | Akcje |
| Swiss National Bank | $371 195 152 | 3 588 160 | 0,48% | Akcje |
| BlackRock, Inc. | $364 982 048 | 3 528 101 | 0,47% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $354 997 941 | 3 431 590 | 0,46% | Akcje |
| National Pension Service | $352 166 145 | 3 404 216 | 0,46% | Akcje |
| ROYAL BANK OF CANADA | $338 495 000 | 3 272 060 | 0,44% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $322 653 390 | 3 118 927 | 0,42% | Akcje |
| GOLDMAN SACHS GROUP INC | $319 964 422 | 3 092 938 | 0,42% | Akcje |
| Legal & General Group Plc | $315 302 980 | 3 047 878 | 0,41% | Akcje |
| Holocene Advisors, LP | $310 524 210 | 3 001 684 | 0,40% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $300 309 006 | 2 902 944 | 0,39% | Akcje |
| CITADEL ADVISORS LLC | $299 591 200 | 2 896 000 | 0,39% | Opcja kupna |
| Sumitomo Mitsui Trust Group, Inc. | $298 855 050 | 2 888 884 | 0,39% | Akcje |
| Vanguard Global Advisers, LLC | $295 578 375 | 2 857 210 | 0,38% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $295 497 373 | 2 856 427 | 0,38% | Akcje |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | $280 502 160 | 2 712 000 | 0,36% | Akcje |
| CITADEL ADVISORS LLC | $267 076 865 | 2 581 700 | 0,35% | Opcja sprzedaży |
| BNP PARIBAS FINANCIAL MARKETS | $261 748 880 | 2 530 197 | 0,34% | Akcje |
| BANK OF AMERICA CORP /DE/ | $249 417 276 | 2 410 993 | 0,32% | Akcje |
| PRIMECAP MANAGEMENT CO/CA/ | $246 778 944 | 2 385 490 | 0,32% | Akcje |
| RHUMBLINE ADVISERS | $246 744 475 | 2 385 158 | 0,32% | Akcje |
| FRANKLIN RESOURCES INC | $238 592 528 | 2 306 356 | 0,31% | Akcje |
| California Public Employees Retirement System | $233 879 967 | 2 260 802 | 0,30% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $232 194 060 | 3 233 000 | 0,30% | Akcje |
| JANE STREET GROUP, LLC | $231 055 575 | 2 233 500 | 0,30% | Opcja sprzedaży |
| CANADA PENSION PLAN INVESTMENT BOARD | $230 615 292 | 2 229 244 | 0,30% | Akcje |
| Canoe Financial LP | $226 952 024 | 2 193 833 | 0,29% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $223 951 974 | 2 164 833 | 0,29% | Akcje |
| VANGUARD GROUP INC | $222 935 255 | 2 809 164 | 0,29% | Akcje |
| UBS Group AG | $221 527 830 | 2 141 400 | 0,29% | Opcja kupna |
| Brandywine Global Investment Management, LLC | $216 103 153 | 2 723 074 | 0,28% | Akcje |
| Robeco Institutional Asset Management B.V. | $207 806 227 | 2 008 760 | 0,27% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $205 293 939 | 1 984 475 | 0,27% | Akcje |
| Point72 Asset Management, L.P. | $202 868 760 | 1 961 032 | 0,26% | Akcje |
| JANUS HENDERSON GROUP PLC | $200 732 734 | 2 794 942 | 0,26% | Akcje |
| JANE STREET GROUP, LLC | $190 306 620 | 1 839 600 | 0,25% | Opcja kupna |
| JONES FINANCIAL COMPANIES LLLP | $186 577 346 | 1 788 167 | 0,24% | Akcje |
| Assenagon Asset Management S.A. | $183 757 718 | 1 776 295 | 0,24% | Akcje |
| MACKENZIE FINANCIAL CORP | $177 786 480 | 1 718 574 | 0,23% | Akcje |
| Hamlin Capital Management, LLC | $177 686 548 | 1 717 608 | 0,23% | Akcje |
| Alyeska Investment Group, L.P. | $174 358 768 | 1 685 440 | 0,23% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $169 576 171 | 1 639 209 | 0,22% | Akcje |
| LPL Financial LLC | $160 912 185 | 1 555 458 | 0,21% | Akcje |
| PRUDENTIAL FINANCIAL INC | $156 319 985 | 1 511 068 | 0,20% | Akcje |
| GOLDMAN SACHS GROUP INC | $153 033 585 | 1 479 300 | 0,20% | Opcja kupna |
| Quantinno Capital Management LP | $150 197 267 | 1 451 882 | 0,20% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $149 812 359 | 1 448 162 | 0,19% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $146 277 266 | 1 413 990 | 0,19% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $143 800 879 | 1 390 052 | 0,19% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $143 310 113 | 1 385 308 | 0,19% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $135 669 704 | 1 889 024 | 0,18% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $133 185 771 | 1 287 441 | 0,17% | Akcje |
| BARCLAYS PLC | $130 962 631 | 1 265 951 | 0,17% | Akcje |
| UBS Group AG | $130 742 593 | 1 263 824 | 0,17% | Akcje |
| MACQUARIE GROUP LTD | $130 222 860 | 1 258 800 | 0,17% | Akcje |
| Patient Capital Management, LLC | $127 813 106 | 1 235 505 | 0,17% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $125 407 000 | 1 212 248 | 0,16% | Akcje |
| Maple Rock Capital Partners Inc. | $123 932 686 | 1 197 996 | 0,16% | Akcje |
| BANK OF MONTREAL /CAN/ | $120 915 774 | 1 168 833 | 0,16% | Akcje |
| Qube Research & Technologies Ltd | $118 745 083 | 1 147 850 | 0,15% | Akcje |
| TD Asset Management Inc | $117 174 298 | 1 132 666 | 0,15% | Akcje |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $114 781 970 | 1 108 148 | 0,15% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $114 360 975 | 1 105 471 | 0,15% | Akcje |
| AVIVA PLC | $113 872 588 | 1 100 750 | 0,15% | Akcje |
| Integral Health Asset Management, LLC | $113 795 000 | 1 100 000 | 0,15% | Akcje |
| LETKO, BROSSEAU & ASSOCIATES INC | $113 305 164 | 1 095 265 | 0,15% | Akcje |
| TRUIST FINANCIAL CORP | $112 799 640 | 1 090 378 | 0,15% | Akcje |
| Woodline Partners LP | $112 125 214 | 1 083 859 | 0,15% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $111 580 653 | 1 078 595 | 0,14% | Akcje |
| STOREBRAND ASSET MANAGEMENT AS | $111 494 582 | 1 077 763 | 0,14% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $110 986 994 | 1 076 081 | 0,14% | Akcje |
| BANK OF NOVA SCOTIA | $103 790 874 | 1 003 295 | 0,13% | Akcje |
| Capital International, Inc./CA/ | $102 952 716 | 995 193 | 0,13% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $100 146 711 | 970 080 | 0,13% | Akcje |
| Walleye Trading LLC | $98 691 300 | 954 000 | 0,13% | Opcja kupna |
| Walleye Trading LLC | $98 049 910 | 947 800 | 0,13% | Opcja sprzedaży |
| Korea Investment CORP | $97 590 385 | 943 358 | 0,13% | Akcje |
| JENNISON ASSOCIATES LLC | $97 539 798 | 942 869 | 0,13% | Akcje |
| SEB Asset Management AB | $96 760 081 | 935 333 | 0,13% | Akcje |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $91 910 670 | 888 455 | 0,12% | Akcje |
Insiderzy spółki 86 insiderów · 48 dyrektorzy generalni · 41 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David J. Joyner | President, CEO and Chair | 1 kwietnia 2026 F | 70 349 | 0 | 0 | $0 |
| Karen S Lynch | President and CEO | 1 kwietnia 2024 A | 74 687 | 0 | 0 | $0 |
| Brian Newman | EVP, Chief Financial Officer | 31 maja 2026 F | 3 008 | 0 | 0 | $0 |
| Thomas F. Cowhey | EVP and CFO | 1 kwietnia 2025 A | 41 109 | 0 | 0 | $0 |
| Shawn M Guertin | EVP & Chief Financial Officer | 1 kwietnia 2023 A | 34 706 | 0 | 0 | $0 |
| Eva C Boratto | EVP & CFO | 4 maja 2021 S | 115 331 | 0 | 0 | $0 |
| David M Denton | EVP and CFO | 29 listopada 2018 S | 403 | 0 | 0 | $0 |
| David B Rickard | Chief Financial Officer | 14 grudnia 2009 M | 207 179 | 0 | 0 | $0 |
| Howard A Mclure | President, Caremark Pharm Serv | 2 listopada 2009 M | 0 | 0 | 0 | $0 |
| Jonathan C Roberts | EVP & Chief Operating Officer | 1 kwietnia 2022 A | 426 025 | 0 | 0 | $0 |
| James David Clark | SVP, Cont & Chief Acct Officer | 26 czerwca 2026 F | 27 606 | 0 | 0 | $0 |
| Amy Compton-Phillips | EVP, Chief Medical Officer | 31 maja 2026 F | 9 557 | 0 | 0 | $0 |
| Tilak Mandadi | EVP, Chief Exp & Tech Officer | 8 maja 2026 S | 10 133 | 0 | 1 | $-6 230 379 |
| Prem S Shah | EVP and Group President | 31 marca 2026 A | 64 356 | 0 | 0 | $0 |
| Heidi B Capozzi | EVP and Chief People Officer | 31 marca 2026 A | 13 023 | 3 | 0 | $4 588 |
| Samrat S. Khichi | EVP, CPO and General Counsel | 31 marca 2026 A | 33 421 | 0 | 0 | $0 |
| Steven H Nelson | EVP and President, Aetna | 31 marca 2026 A | 2 900 | 1 | 0 | $1 289 |
| Sreekanth K Chaguturu | EVP and Chief Medical Officer | 1 kwietnia 2024 A | 23 666 | 0 | 0 | $0 |
| Laurie P. Havanec | EVP and Chief People Officer | 1 kwietnia 2024 A | 9 426 | 0 | 0 | $0 |
| Brian A Kane | EVP/President, Aetna | 1 kwietnia 2024 A | 12 569 | 0 | 0 | $0 |
| Finke Daniel P | EVP/Pres, Health Care Benefits | 1 kwietnia 2023 A | 35 068 | 0 | 0 | $0 |
| Michelle A Peluso | EVP and Co-President of Retail | 1 kwietnia 2023 A | 124 383 | 0 | 0 | $0 |
| Thomas M Moriarty | EVP & General Counsel | 31 grudnia 2022 F | 315 273 | 0 | 0 | $0 |
| Alan Lotvin | EVP&President-PharmacyServices | 4 sierpnia 2022 M | 109 183 | 0 | 0 | $0 |
| Troyen A Brennan | EVP and Chief Medical Officer | 3 kwietnia 2022 F | 232 676 | 0 | 0 | $0 |
| Neela Montgomery | EVP and Pres., Pharmacy/Retail | 1 kwietnia 2021 A | 29 502 | 0 | 0 | $0 |
| Lisa Bisaccia | Former EVP & Chief HR Officer | 1 kwietnia 2021 F | 66 417 | 0 | 0 | $0 |
| Joshua Matthew Flum | EVP, ENT STRATEGY & DIGITAL | 28 lutego 2021 F | 25 657 | 0 | 0 | $0 |
| Jonathan E. Mayhew | EVP - Transformation | 2 grudnia 2020 F | 6 855 | 0 | 0 | $0 |
| Derica W Rice | EVP & President, CVS Caremark | 28 lutego 2020 F | 26 827 | 0 | 0 | $0 |
| Kevin Hourican | EVP & President, CVS Pharmacy | 1 kwietnia 2019 A | 15 237 | 0 | 0 | $0 |
| Helena Foulkes | EVP & President-CVS Pharmacy | 16 lutego 2018 M | 45 107 | 0 | 0 | $0 |
| Robert O. Kraft | EVP and President - Omnicare | 3 kwietnia 2017 A | 92 360 | 0 | 0 | $0 |
| Andrew Sussman | EVP, Clinical Services | 3 kwietnia 2017 A | 16 433 | 0 | 0 | $0 |
| Stephen J Gold | EVP & CIO | 3 kwietnia 2017 A | 46 818 | 0 | 0 | $0 |
| Per Gh Lofberg | EVP | 2 stycznia 2015 M | 23 419 | 0 | 0 | $0 |
| Mark Cosby | EVP & President-CVS/pharmacy | 30 września 2013 M | 45 955 | 0 | 0 | $0 |
| Laird Daniels | SVP, Cont & Chief Acct Officer | 1 kwietnia 2013 A | 17 845 | 0 | 0 | $0 |
| Douglas A Sgarro | EVP and CLO | 11 maja 2012 M | 214 | 0 | 0 | $0 |
| Stuart M Mcguigan | SVP and CIO | 16 marca 2012 M | 10 967 | 0 | 0 | $0 |
| Thomas M Ryan | Non-Executive Chairman | 3 kwietnia 2011 F | 1 156 702 | 0 | 0 | $0 |
| Sara Finley | SVP, Gen Counsel | 18 lutego 2011 F | 29 053 | 0 | 0 | $0 |
| Michael V Ferdinandi | Senior Vice President | 19 sierpnia 2009 S | 16 021 | 0 | 0 | $0 |
| Paula A Price | Controller | 12 lutego 2008 A | 16 498 | 0 | 0 | $0 |
| Edwin M Crawford | Chairman | 29 października 2007 A | 135 572 | 0 | 0 | $0 |
| William R Spalding | EVP Caremark Pharmacy Services | 18 czerwca 2007 M | 182 | 0 | 0 | $0 |
| Gregory S Weishar | Vice President | 3 kwietnia 2006 A | 30 161 | 0 | 0 | $0 |
| Larry D Solberg | Senior Vice President | 16 lutego 2006 A | 5 978 | 0 | 0 | $0 |
| ROBBINS LARRY | Dyrektor | 21 maja 2026 S | 4 824 799 | 0 | 8 | $-352 750 556 |
| Fernando Aguirre | Dyrektor | 21 maja 2026 D | 10 513 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| CVS Caremark Corporation | 7 stycznia 2011 | — | Pierwotne zgłoszenie | M&A / sprzedaż | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 219 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHF · iShares Trust | 13,19% | 1 718 337 SH | 20 sierpnia 2026 | Dziennie |
| ROPE · EA Series Trust | 5,27% | 4 922 NS | 29 maja 2026 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 4,57% | 636 042 NS | 30 kwietnia 2026 | N-PORT |
| IYK · iShares Trust | 4,09% | 621 096 SH | 20 sierpnia 2026 | Dziennie |
| GEND · Spinnaker ETF Series | 3,66% | 1 968 NS | 30 kwietnia 2026 | N-PORT |
| PEZ · Invesco Exchange-Traded Fund Trust | 3,50% | 8 583 SH | 20 sierpnia 2026 | Dziennie |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,71% | 3 618 NS | 30 kwietnia 2026 | N-PORT |
| ESN · Northern Lights Fund Trust II | 2,58% | 79 142 NS | 31 maja 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 2,33% | 158 312 NS | 30 kwietnia 2026 | N-PORT |
| SDOG · ALPS ETF Trust | 2,25% | 342 879 NS | 31 maja 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 2,16% | 4 706 232 NS | 30 kwietnia 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 2,15% | 12 078 NS | 30 kwietnia 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 1,94% | 3 824 297 SH | 19 sierpnia 2026 | Dziennie |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,90% | 2 030 141 SH | 20 sierpnia 2026 | Dziennie |
| FXG · First Trust Exchange-Traded AlphaDE… | 1,89% | 55 579 NS | 30 kwietnia 2026 | N-PORT |
| SPDV · ETF Series Solutions | 1,86% | 20 100 NS | 30 kwietnia 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1,81% | 335 979 SH | 20 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 1,71% | 585 200 NS | 30 kwietnia 2026 | N-PORT |
| RXL · ProShares Trust | 1,67% | 13 266 NS | 31 maja 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 1,55% | 52 621 NS | 30 kwietnia 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,53% | 25 368 NS | 30 kwietnia 2026 | N-PORT |
| IXJ · iShares Trust | 1,43% | 670 400 SH | 20 sierpnia 2026 | Dziennie |
| SPVM · Invesco Exchange-Traded Fund Trust | 1,41% | 20 951 SH | 20 sierpnia 2026 | Dziennie |
| ITAN · EA Series Trust | 1,36% | 13 295 NS | 29 maja 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,35% | 120 625 SH | 20 sierpnia 2026 | Dziennie |
| PWV · Invesco Exchange-Traded Fund Trust | 1,33% | 264 722 SH | 20 sierpnia 2026 | Dziennie |
| VLUE · iShares Trust | 1,31% | 1 367 833 SH | 20 sierpnia 2026 | Dziennie |
| DVY · iShares Trust | 1,30% | 3 337 377 SH | 20 sierpnia 2026 | Dziennie |
| GMOV · GMO ETF Trust | 1,21% | 12 118 NS | 31 maja 2026 | N-PORT |
| GURU · Global X Funds | 1,17% | 8 187 NS | 30 kwietnia 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 1,16% | 40 484 000 | 20 sierpnia 2026 | Dziennie |
| SPVU · Invesco Exchange-Traded Fund Trust … | 1,13% | 16 706 NS | 31 maja 2026 | N-PORT |
| SPXD · DBX ETF Trust | 1,12% | 830 NS | 31 maja 2026 | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trust … | 1,09% | 31 567 000 | 20 sierpnia 2026 | Dziennie |
| CVAR · ETF Opportunities Trust | 1,01% | 4 716 NS | 30 kwietnia 2026 | N-PORT |
| CGCV · Capital Group Conservative Equity E… | 0,99% | 189 872 NS | 31 maja 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,98% | 27 132 NS | 30 kwietnia 2026 | N-PORT |
| ABCS · EA Series Trust | 0,98% | 1 219 NS | 29 maja 2026 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 0,97% | 2 025 NS | 30 kwietnia 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,95% | 77 895 SH | 19 sierpnia 2026 | Dziennie |
| FNDX · SCHWAB STRATEGIC TRUST | 0,91% | 2 553 383 NS | 31 maja 2026 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 0,89% | 269 782 SH | 20 sierpnia 2026 | Dziennie |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,85% | 88 858 SH | 20 sierpnia 2026 | Dziennie |
| AKAF · ETF Series Solutions | 0,84% | 271 NS | 31 maja 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,83% | 120 850 NS | 31 maja 2026 | N-PORT |
| WBIG · Absolute Shares Trust | 0,82% | 2 174 NS | 30 czerwca 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,81% | 529 096 NS | 30 kwietnia 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,81% | 10 773 NS | 30 kwietnia 2026 | N-PORT |
| SNPV · DBX ETF Trust | 0,79% | 19 940 NS | 29 maja 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,75% | 50 750 SH | 19 sierpnia 2026 | Dziennie |